Brompton Lifeco Split (TSX:LCS) Research & Development: C$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:LCS Brompton Lifeco Split Corp TSX:LCS
38 GF Score
Price C$12.73
! 7 Warning Signs
View Full Analysis

What is Brompton Lifeco Split Research & Development?

Brompton Lifeco Split TSX:LCS +1.03% 38 Research & Development is C$0.00 Mil as of Dec. 2025. GuruFocus rates TSX:LCS with a GF Score™ of 38/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Brompton Lifeco Split's Research & Development for the six months ended in Dec. 2025 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was C$0.00 Mil.

Brompton Lifeco Split  (TSX:LCS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Brompton Lifeco Split Research & Development Related Terms

Brompton Lifeco Split Research & Development Historical Data

* Premium members only.

The historical data trend for Brompton Lifeco Split's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brompton Lifeco Split Research & Development Chart

Brompton Lifeco Split Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Brompton Lifeco Split Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSX:LCS
38GF Score
Brompton Lifeco Split Corp TSX:LCS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brompton Lifeco Split Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.00 Mil mean?
Brompton Lifeco Split (TSX:LCS) has a Research & Development of C$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Brompton Lifeco Split and its competitors.
Is Brompton Lifeco Split's Research & Development too high?
Brompton Lifeco Split's current Research & Development is C$0.00 Mil. Overall, Brompton Lifeco Split has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Brompton Lifeco Split's Research & Development compare to BLK and BX?
Brompton Lifeco Split's Research & Development of C$0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Brompton Lifeco Split and its competitors. Brompton Lifeco Split's current Research & Development is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brompton Lifeco Split stock overvalued right now?
Brompton Lifeco Split (TSX:LCS) has a current Research & Development of C$0.00 Mil. The current Research & Development is C$0.00 Mil. Brompton Lifeco Split's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Brompton Lifeco Split (TSX:LCS), the current Research & Development is C$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brompton Lifeco Split Business Description

Other Exchanges LCS.PR.A.PFD:Canada
Address 181 Bay Street, Suite 2930, Box 793, Bay Wellington Tower, Brookfield Place, Toronto, ON, CAN, M5J 2T3
Brompton Lifeco Split Corp is a mutual fund corporation based in Canada. It invests in a portfolio comprised of common shares of publicly traded Canadian life insurance companies. The Fund's objectives in managing its capital are to provide holders of Preferred shares with fixed, cumulative, preferential quarterly cash distributions and to return the original issue price to the holders of the shares on the maturity date, the terms of which may be extended for periods of up to five years as determined by the Board of Directors, and to provide holders of Class A shares with regular monthly cash distributions targeted share and the opportunity for growth in Net Asset Value per share. Its products are ETFs, Other TSX Traded Funds, Preferred Shares, Split Share Class A Share Investments.
38GF Score

Get the complete analysis for TSX:LCS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$12.73
Price